Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to lungs. GlobalData uses proprietary data and analytics to provide a comprehensive report on the inferior vena cava filters devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the inferior vena cava filters market in New Zealand was Argon Medical Devices followed by Mermaid Medical, ALN implants chirurgicaux, B. Braun Melsungen, LifeTech Scientific, Becton Dickinson and Co, Merit Medical Systems, Cook Group, Boston Scientific and Cardinal Health.
The filter is inserted inside a large vein called the inferior vena cava (which carries blood from lower extremities to the heart). IVC filter traps blood clots before it reaches to the lungs. It is commonly used as a preventive measure in cases where DVT and PE has been diagnosed or as a prophylactic device in cases where the risk of developing VTE is high and there is a contraindication for anticoagulants. Usage of IVC filters can prevent PE, but it does not restrict blood clot formation. IVC filters are made of non-ferromagnetic materials [Cobalt Chromium Alloy, Stainless Steel, Titanium, Nickel-Titanium (Nitinol)]. Permanent, Retrievable IVC filters and IVCF Retrieval Devices have been tracked under this segment. Permanent inferior vena cava filters (IVCF) once inserted cannot be removed or repositioned. Retrievable inferior vena cava filters (IVCF) once inserted can be retrieved or repositioned up to a certain point of time. Optional Retrievable inferior vena cava filters are used to prevent pulmonary embolism when anticoagulation is ineffective. Temporary Retrievable inferior vena cava filters are used to prevent the risk of PE for a short duration and should be ideally retrieved within 30 to 60 days. IVCF Retrieval Devices are used for removal of Retrievable IVC Filters from the vena cava.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the inferior vena cava filters devices market within New Zealand was expected to be over $1.9001e+006m in 2022.
For the latest complete market share analysis of inferior vena cava filters device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
